SEC Form 4 · accession 0001209191-17-034724
ENDRA Life Sciences Inc. · NDRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sanjiv Sam Gambhir
Director
Period of report
May 12, 2017
Accepted (ET)
May 23, 2017 · 5:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001681682
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $5.00 | May 12, 2017 | A | 6,000 | A | May 12, 2017 | May 12, 2025 | Common Stock | 6,000 | 6,000 | D |
| Stock Options | $5.00 | May 12, 2017 | A | 6,000 | A | Dec 31, 2017 | May 12, 2025 | Common Stock | 6,000 | 6,000 | D |